Latest Breaking News On - Palatin technologies inc - Page 7 : comparemela.com

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Palatin s Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED).

United statesCarl spanaPalatin technologies incCosette pharmaceuticalsPrnewswire palatin technologies incVyleesi to cosette pharmaceuticalsMetabolic program obesityAsset sale to cosette pharmaceuticalsSexual health program male dysfunctionBremelanotide coSecurities exchangeMelanocortin receptorDry eye diseaseTopline data expectedUlcerative colitisInterim analysis expected

HC Wainwright Reaffirms Buy Rating for Palatin Technologies (NYSEAMERICAN:PTN)

HC Wainwright Reaffirms Buy Rating for Palatin Technologies (NYSEAMERICAN:PTN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesVanguard group incRenaissance technologiesArmistice capitalPalatin technologies incMillennium managementPalatin technologiesGet free reportTechnologies trading downStreet corpPalatin technologies daily

Palatin Technologies (NYSEAMERICAN:PTN) Releases Earnings Results

Palatin Technologies (NYSEAMERICAN:PTN) Releases Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPalatin technologies company profilePalatin technologies incArmistice capitalRenaissance technologiesMillennium managementVanguard group incPalatin technologiesGet free reportTechnologies trading downStreet corpPalatin technologies daily

Palatin Technologies (NYSEAMERICAN:PTN) Posts Quarterly Earnings Results, Misses Estimates By $0 36 EPS

Palatin Technologies (NYSEAMERICAN:PTN) Posts Quarterly Earnings Results, Misses Estimates By $0 36 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAsset management incDimensional fund advisorsPalatin technologies incNorthern trust corpPalatin technologiesGet free reportTechnologies stock downTrust corpManagement incFund advisorsJane street groupPalatin technologies daily

HC Wainwright Reaffirms Buy Rating for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They presently have a $70.00 target price on the biopharmaceutical company’s stock. Palatin Technologies Trading Down 23.2 % NYSEAMERICAN PTN traded down $0.96 on Thursday, hitting […]

United statesRenaissance technologiesPalatin technologies incMillennium managementVanguard group incArmistice capitalPalatin technologiesGet free reportTechnologies trading downStreet corpPalatin technologies daily